Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine for Sleep Disturbances in Children With ASD
NCT02812368Phase 2Withdrawn
- Sponsor
- The Ohio State University
- Start
- Aug 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clonidine in sleep disorder, sponsored by The Ohio State University. Planned start Aug 2016; status: withdrawn.
02
Drugs
clonidine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT02812368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812368.